skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

184 Total results for product and free and sample content found

Pink Sheet

UK Election Extends Industry Wait For Accelerated Access Review Response

By Vibha Sharma 26 Apr 2017

The UK government’s response to the Accelerated Access Review report is on hold until after the snap general election in June.

Topic BioPharmaceutical

Meddevicetracker

Discover the top medtech stories from the last week below

By Christopher Lowe 24 Apr 2017

Meddevicetracker weekly round up

Topic Medtech weekly roundup Medtech

Medtech Insight

US FDA Device Center Pushes 'Total Product Life Cycle' Concept; 'Reorganization' Coming, Says Compliance Chief

By Shawn M. Schmitt 24 Apr 2017

The Center for Devices and Radiological Health is shaking up how its pre- and post-market specialists interact under a new "Total Product Life Cycle" scheme.

Scrip

Scrip Asks... Microbiome - Hype Or Happening?

24 Apr 2017

Buzz is growing over the potential of research on the microbiome to yield new therapeutics. Scrip asked pharma, academics and venture capitalists how long it might take to see results, what breakthroughs are needed and which therapeutic areas might benefit first.

Topic Microbiome

Pink Sheet

Ringside For Zarxio At Supreme Court: Biosimilar Stakeholders Line Up

By Brenda Sandburg 23 Apr 2017

High court set to determine timing of biosimilar marketing and how parties handle patent disputes in Sandoz v. Amgen. Stakeholders say the outcome will impact innovation, access to biosimilars and future litigation.  

Topic Biosimilars

Pink Sheet

Brexit: UK Could Be Asked To Foot EMA Relocation Bill; Bidding Criteria Drafted

By Ian Schofield 23 Apr 2017

The European Commission has produced draft Brexit negotiating directives in which it suggests that the UK should bear the cost of moving the European Medicines Agency from London to elsewhere in the EU.

Topic Brexit

Pharmaprojects, Sitetrove, Trialtrove

R and D Annual Review Webinar 2017

19 Apr 2017

The R&D Annual Review webinar is happening soon. Take a look back at pharma R&D in 2016 and look ahead to the remainder of the year to get expert insight from the senior experts at Pharma Intelligence during this free webinar.

Topic Drug development landscape

Datamonitor Healthcare

Big Pharma Outlook 2026 Webinar Save The Date

By Ali Al-Bazergan 19 Apr 2017

Join us on the 15th of May for the Big Pharma Outlook webinar. 

Topic Company analysis Diseases

Pink Sheet

Times Have Changed: FDA Ends ESA REMS Ahead Of First Biosimilars

By Michael McCaughan 19 Apr 2017

FDA is ending one of the landmark drug safety programs from the REMS era, announcing it has released Amgen from its mandatory obligations for the erythropoiesis-stimulating agent (ESA) class. The decision comes just ahead of the likely approval of the first biosimilar application in the class.

Topic Biosimilars

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: